M1 Kliniken AG Announces Share Buyback Program

M1 Kliniken AG, based in Berlin, announced on April 26, 2024, that its Management Board has approved a share buyback program. The company plans to repurchase up to 1,000,000 shares with a total value not exceeding EUR 12,600,000.00. This initiative, authorized by the shareholders during the General Meeting on July 9, 2020, will begin on April 29, 2024, and is set to conclude by April 25, 2025.

The execution of the buyback will be managed by an independent credit institution or investment firm, which will be responsible for the timing of the share purchases. The stated purpose of this buyback is to utilize the repurchased shares for various authorized objectives, in line with the provisions set during the 2020 General Meeting. The company confirms that the program will adhere to the regulatory safe harbor provisions under the Market Abuse Regulation (EU) No. 596/2014 and associated delegated regulations.